Detalles de la búsqueda
1.
Efficacy of switches within the class of IL-17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targeted therapy (BIOREP).
Dermatol Ther
; 35(10): e15772, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36065488
2.
Patient-reported symptoms are a more reliable predictor of the societal burden compared to established physician-reported activity indices in inflammatory bowel disease: a cross-sectional study.
Expert Rev Gastroenterol Hepatol
; 17(1): 99-108, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36537197
3.
Efficacy, safety, and drug survival of patients with psoriasis treated with IL-17 inhibitors - brodalumab, ixekizumab, and secukinumab: real-world data from the Czech Republic BIOREP registry.
J Dermatolog Treat
; 33(6): 2827-2837, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35635185
4.
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic.
Dermatol Ther (Heidelb)
; 11(4): 1345-1355, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089479
5.
Ultrahypofractionated Proton Radiation Therapy in the Treatment of Low and Intermediate-Risk Prostate Cancer-5-Year Outcomes.
Int J Radiat Oncol Biol Phys
; 110(4): 1090-1097, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587990
Resultados
1 -
5
de 5
1
Próxima >
>>